Skip to main content

In risk we trust/Editing embryos and mirroring future risks and uncertainties

Medicine, Health Care and Philosophy volume 22, pages 191–200 (2019)Cite this article

Abstract

Tendencies and efforts have shifted from genome description, DNA mapping, and DNA sequencing to active and profound re-programming, repairing life on genetic and molecular levels in some parts of contemporary life science research. Mirroring and materializing this atmosphere, various life engineering technologies have been used and established in many areas of life sciences in the last decades. A contemporary progressive example of one such technology is DNA editing. Novel developments related to reproductive technologies, particularly embryo editing, prenatal human life engineering, and germline engineering need to be analyzed against the broader social and structural background. The crucial analytical scope for this paper is a specific field: the life-editing technologies used in reproductive medicine and performed experimentally on viable human embryos, particularly CRISPR/Cas9 technology. This text argues that germline editing technologies, as a representative part of contemporary biomedicine, are merging ideas of treatment and enhancement to avoid future risks. Using this specific life manipulation of embryos and gametes, the text analyzes these processes within the concept of power over life—biopower and the specific governing rationality that imagines, classifies, and governs contemporary societies. The text specifically focuses on the potential to create, define, and manage future risks and uncertainties related to prenatal life.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price includes VAT (USA)
Tax calculation will be finalised during checkout.

Notes

  1. Clustered Regularly Interspaced Short Palindromic Repeat. See also Redman et al. (2016).

  2. CRISPR/Cas9 technology has been used since the 1970s, when the first DNA-cutting enzymes were discovered.

  3. “There are three major settings in which genome editing can be applied in biomedicine: (1) basic research that helps advance understanding of human disease and its treatment; (2) clinical applications to treat or prevent disease or disability in somatic cells (non-reproductive cells), and; (3) clinical applications to treat or prevent disease or disability in germline cells (reproductive cells)” http://studyres.com/doc/17254330/human-genome-editing-%E2%80%93-science--ethics--and-governance).

  4. https://www.nature.com/news/uk-scientists-gain-licence-to-edit-genes-in-human-embryos-1.19270.

  5. http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=12032015a.

  6. See also Jinek et al. (2013).

  7. https://www.geneticsandsociety.org/article/new-eugenics-case-against-genetically-modified-humans.

  8. https://www.nature.com/articles/nbt.4018.

  9. See also Vogel and Stokstad (2015).

  10. PGD is preimplantation genetic diagnosis, profiling embryos to identify genetic diseases and pathological mutations and involving their potential selection. The technology is used in assisted reproduction.

  11. Often interpreted as abnormalities or defects.

  12. The concept of bio-objects is based on the COST project: Bio-objects and their boundaries: governing matters at the intersection of society, politics, and science (http://www.cost.eu/COST_Actions/isch/IS1001). Sociologists involved in this project suggest analyzing the processes of bio-objectification, i.e. how various manifestations of life are created and given life or multiple lives. Life itself is dealt with primarily by life sciences, even more now that life has become manageable on molecular and genetic levels. This often causes essentialization, which is why the team of scientists from the COST project wanted to address the processes of objectification—the materialization of life into objects: to avoid the reduction that sees life itself as only cells, genes, etc.

  13. For example, aging is not an illness officially, but it is medicalized extensively (see Conrad’s texts about biomedicalization).

  14. Foucault used the term bio-power “to designate what brought life and its mechanisms into the realm of explicit calculations and made knowledge-power an agent of transformation of human life. … For millennia, man remained what he was for Aristotle: a living animal with the additional capacity for a political existence; modern man is an animal whose politics places his existence as a living being in question … If the question of man was raised—insofar as he was a specific living being, and specifically related to other living beings” (Foucault 1978, p. 143).

  15. http://www8.nationalacademies.org/onpinews/newsitem.aspx?RecordID=1203201.

  16. See also Heavey (2015) or Schyfter et al. (2015).

  17. This is also supported by the objectification of the vital systems as stressed by Calvert: “slightly more reflection is found in a Science article which at least recognises that there is a gap between the organism and the computer programme in saying that ‘Synthetic biologists eventually aim to make bacteria into tiny programmable computers’” (Ferber in Calvert 2010, p. 10).

  18. “The introduction of agriculture, for instance, played a role not only in shaping our environment, but has fundamentally changed our genomes. The same could be said about technologies such as literacy and numeracy, which laid the foundations for technological innovations that have significantly changed us” (Buchanan 2008, 2011 in Cavaliere 2017).

References

  • Adam, Barbara, Ulrich Beck, and Joost van Loon. 2000. The Risk Society and Beyond. Critical Issues for Social Theory. London: SAGE.

    Book  Google Scholar 

  • Agamben, Giorgio. 1998. Homo Sacer: Sovereign Power and Bare Life. Stanford: Stanford University Press.

    Google Scholar 

  • Ascott, Roy, and Edward A. Shanken. 2003. Telematic Embrace: Visionary Theories of Art, Technology, and Consciousness. Berkeley: University of California Press.

    Google Scholar 

  • Atkinson, Paul, Peter Glasner, and Margaret Lock. 2013. Handbook of Genetics and Society, Mapping the New Genomic Era. London: Rouledge.

    Google Scholar 

  • Baltimore, David et al. 2015. A prudent path forward for genomic engineering and germline gene modification. Biotechnology 348 (6230): 36–38. https://doi.org/10.1126/science.aab1028.

    Google Scholar 

  • Beck, Ulrich. 1986/1992. Risk Society. Towards a New Modernity. London: SAGE.

  • Best, Jacqueline. 2008. Ambiguity, uncertainty, and risk: Rethinking indeterminacy. International Political Sociology 2 (4): 355–374. https://doi.org/10.1111/j.1749-5687.2008.00056.x.

    Article  Google Scholar 

  • Bock von Wülfingen, Bettina. 2012. From re-pair and re-production to (re)generation: Bio-objects as indicators of cultural change. Croatian Medical Journal 53 (5): 502–504.

    Article  Google Scholar 

  • Braun, B. 2007. Biopolitics and the molecularization of life. Cultural Geographies 14 (1): 6–28.

    Article  Google Scholar 

  • Brown, Nik, and Andrew Webster. 2004. New Medical Technologies and Society: Reordering life. Cambridge: Polity.

    Google Scholar 

  • Burchell, Graham, Colin Gordon, and Peter Miller. 1991. Foucault Effect: Studies in Governmentality. Chicago: University of Chicago Press.

    Book  Google Scholar 

  • Calvert, Jane. 2010. Synthetic biology: Constructing nature? The Sociological Review. https://doi.org/10.1111/j.1467-954X.2010.01913.x.

    Google Scholar 

  • Calvert, Jane. 2013. Engineering biology and society: Reflections on synthetic biology. Science, Technology & Society 18 (3): 405–420.

    Article  Google Scholar 

  • Calvert, Jane, and Joan H. Fujimura. 2011. Calculating life? Duelling discourses in interdisciplinary systems biology. Studies in History and Philosophy of Biological and Biomedical Sciences 42 (2): 155–163.

    Article  Google Scholar 

  • Canguilhem, Georges. 1988. Ideology and Rationality in the History of the Life Sciences. Cambridge: MIT Press.

    Google Scholar 

  • Canguilhem, Georges. 1991. The Normal and the Pathological, Trans. Carolyn R. Fawcett, Robert S. Cohen. New York: Zone Books.

  • Canguilhem, Georges. 2008. The Knowledge of Life. New York: Fordham UP.

    Google Scholar 

  • Cavaliere, Giulia. 2017. Genome editing and assisted reproduction: Curing embryos, society or prospective parents? Medicine, Health Care and Philosophy. https://doi.org/10.1007/s11019-017-9793-y.

    Google Scholar 

  • Collier, Stephen J., and Andrew Lakoff. 2008. On regimes of living. In Global Assemblages: Technology, Politics, and Ethics as Anthropological Problems, eds. Collier, Stephen J., Andrew Lakoff, and Paul Rabinow. New York: Blackwell.

    Google Scholar 

  • Collins, Francis S. 2015. Statement on the NIH funding of research using gene-editing technologies in human embryos. National Institute of Health (NIH). http://www.nih.gov/about-nih/who-we-are/nihdirector/statements/statement-nih-funding-research-using-gene-editing-technologies-human-embryos. Accessed 15 December 2017.

  • Conrad, Peter, and Jonathan Gabe. 1999. Introduction: Sociological perspectives on the new genetics: An overview. Sociology of Health & Illness 21 (5): 505–551. https://doi.org/10.1111/1467-9566.00170.

    Article  Google Scholar 

  • Csete, M., and J. C. Doyle. 2002. Reverse engineering of biological complexity. Science 295 (5560): 1664–1669. https://doi.org/10.1126/science.1069981.

    Article  Google Scholar 

  • Dean, Mitchell. 1999. Governmentality. Power and Rule in Modern Society. London: SAGE.

    Google Scholar 

  • Dreyfus, Hubert L, and Rabinow, Paul. 1983. Michel Foucault: Beyond Structuralism and Hermeneutics. Chicago: University of Chicago Press.

    Book  Google Scholar 

  • Foucault, Michel. 1978. The History of Sexuality, Volume I. Introduction. New York: Pantheon Books.

    Google Scholar 

  • Foucault, Michel. 1982. The subject and power. Critical Inquiry 8 (4): 777–795.

    Article  Google Scholar 

  • Foucault, Michel. 2007. Security, Territory, Population. Lectures at the Collège de France 1977–78. London: Palgrave Macmillan.

    Google Scholar 

  • Foucault, Michel. 2008. The Birth of Biopolitics: Lectures at the Collège de France, 1978–1979. New York: Picador.

    Google Scholar 

  • Franklin, Sarah. 2013. Biological Relatives. IVF, Stem Cells, and the Future of Kinship. Durham: Duke University Press.

    Book  Google Scholar 

  • Franklin, Sarah, and Susan McKinnon. 2001. Relative Values: Reconfiguring Kinship Studies. Durham: Duke University Press.

    Google Scholar 

  • Fujimura, Joan H. 2005. Postgenomic futures: Translations across the machine-nature border in systems biology. New Genetics and Society 24 (2): 195–225.

    Article  Google Scholar 

  • Giddens, Anthony. 1990. The Consequences of Modernity. Cambridge: Polity Press.

    Google Scholar 

  • Glad, John. 2006. Future Human Evolution: Eugenics in the Twenty-First Century. Hermitage Publishers.

  • Gottweis, Herbert. 2005. Comparing Biobanks: Towards a New Form of Biopolitics? Lecture for the International Comparison of IHTs Workshop, Rome.

  • Haraway, Donna. 1991. Simians, Cyborgs and Women. NewYork: Routledge.

    Google Scholar 

  • Haraway, Donna. 2008. When Species Meet. Minneapolis: University of Minnesota Press.

    Google Scholar 

  • Harris, John. 2007. Enhancing Evolution: the Ethical Case for Making People Better. Princeton, Oxford: Princeton University Press.

    Google Scholar 

  • Heavey, Patrick. 2015. Integrating ethical analysis “Into the DNA” of synthetic biology. Medicine, Health Care and Philosophy 18 (1): 121–127. https://doi.org/10.1007/s11019-014-9588-3.

    Article  Google Scholar 

  • Helmreich, Stefan. 2011. What was life? Answers from three limit biologies. Critical Inquiry 37 (4): 671–696.

    Article  Google Scholar 

  • Holmberg, Tora, Nete Schwennesen, and Andrew Webster. 2011. Bio-objects and the bio-objectification process. Croatian Medical Journal 52 (6): 740–742.

    Article  Google Scholar 

  • Jinek, Martin, Alexandra East, Aaron Cheng, Steven Lin, Enbo Ma, and Jennifer Doudna. 2013. RNA-programmed genome editing in human cells. eLIFE. https://doi.org/10.7554/eLife.00471.

    Google Scholar 

  • Kac, Eduardo, ed. 2007. Signs of Life. Cambridge: Massachusetts Institute of Technology.

    Google Scholar 

  • Kerr, Anne, and Sarah Cunningham-Burley. 2000. On ambivalence and risk: Reflexive modernity and the new human genetics. Sociology 34 (2): 283–304.

    Article  Google Scholar 

  • Kirksey, Eben S., and Stefan Helmreich. 2010. The emergence of multispecies etnography. Cultural Anthropology 25 (4): 545–575.

    Article  Google Scholar 

  • Lemke, Thomas. 2004. Disposition and determinism. Genetic diagnosis in risk society. The Sociological Review 52 (4): 550–566. https://doi.org/10.1111/j.1467-954X.2004.00495.x.

    Article  Google Scholar 

  • Lemke, Thomas. 2005. From eugenics to the government of genetic risk. In Genetic Governance. Health, Risk and Ethics in the Biotech Era, eds. Robin Bunton and Alan Petersen. London: Routledge.

    Google Scholar 

  • Lemke, Thomas. 2011. Biopolitics: An Advanced Introduction (Biopolitics: Medicine, Technoscience, and Health in the 21st Century). New York: New York University Press.

    Google Scholar 

  • Lemke, Thomas. 2013. Perspectives on Genetic Discrimination. New York: Routledge.

    Book  Google Scholar 

  • Lupton, Deborah. 1999. Risk and Sociocultural Theory: New Directions and Perspectives. Cambridge: Cambridge University Press.

    Book  Google Scholar 

  • Lupton, Deborah. 2013. Risk. 2nd ed. London: Routledge.

    Google Scholar 

  • Mulvihill, J.J., et al. 2017. Ethical issues of CRISPR technology and gene editing through the lens of solidarity. British Medical Bulletin 122 (1): 17:17–29. https://doi.org/10.1093/bmb/ldx002.

    Article  Google Scholar 

  • Nilsson, Jakob, and Sven-Olov Wallenstein. 2013. Foucault, Biopolitics and Governmentality. Stockholm: Södertörn Philosophical Studies.

    Google Scholar 

  • Rabinow, Paul. 1996. Artificiality and enlightenment: From sociobiology to biosociality. In Anthropologies of Modernity: Foucault, Governmentality and Life Sciences, ed. J. X. Inda, 181–193. Oxford: Blackwell.

    Google Scholar 

  • Rabinow, Paul. 2003. Anthropos Today. Reflections on Modern Equipment. Princeton: Princeton University Press.

    Google Scholar 

  • Rabinow, Paul, and Gaymon Bennett. 2012. Synthetic biology, ethical ramifications. Systems and Synthetic Biology 3 (1–4): 99–108.

    Google Scholar 

  • Rabinow, Paul, and Nikolas Rose. 2006. Biopower today. BioSocieties 1 (2): 195–217.

    Article  Google Scholar 

  • Rapp, Rayana. 2000. Testing the Fetus. The Social Impact of Amniocentesis in America. New York: Routledge.

    Google Scholar 

  • Raz, Aviad E. 2009. Eugenic utopias/dystopias, reprogenetics, and community genetics. Sociology of Health & Illness 31 (4): 602–616. https://doi.org/10.1111/j.1467-9566.2009.01160.x.

    Article  Google Scholar 

  • Redman, Melody, Andrew King, Caroline Watson, and David King. 2016. What is CRISPR/Cas9? Archives of Disease in Childhood. Education and Practice Edition 101 (4): 213–215. https://doi.org/10.1136/archdischild-2016-310459.

    Article  Google Scholar 

  • Rettner, Rachael. 2016. Controversial Human Embryo Editing: 5 Things to Know. Life Science, September 23. http://www.livescience.com/56243-human-embryo-editing.html. Accessed 15 December 2016.

  • Rose, Nikolas. 2007. The Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty First Century. Princeton: Princeton University Press.

    Book  Google Scholar 

  • Saey, Tina H. 2016. New era of human embryo gene editing begins. Science News, Magazine of the Society & Public, September 23. https://www.sciencenews.org/article/new-era-human-embryo-gene-editing-begins. Accessed 2 February 2017.

  • Schyfter, Camacho P., and Jane Calvert. 2015. Intentions, expectations and institutions: Engineering the future of synthetic biology in the US and the UK. Science as Culture 24 (4): 359–383.

    Article  Google Scholar 

  • Šmídová, Iva, Eva Šlesingerová a Lenka Slepičková. 2015. Games of Life. Czech Reproductive Biomedicine. Sociological Perspectives. Brno: Munipress. https://doi.org/10.5817/CZ.MUNI.M210-7734-2015.

  • Sontag, Susan. 1977. Illness as Metaphor. New York: Farrar Straus and Giroux.

    Google Scholar 

  • Strathern, Marilyn. 1996. After Nature: English Kinship in the Late Twentieth Century. New York: Cambridge University Press.

    Google Scholar 

  • Trommelmans, Leen, Joseph Selling, and Kris Dierickx. 2009. Is tissue engineering a new paradigm in medicine? Consequences for the ethical evaluation of tissue engineering research. Medicine, Health Care and Philosophy 12 (4): 459–467.

    Article  Google Scholar 

  • Vogel, Gretchen, and Erik Stokstad. 2015. U.K. Parliament approves controversial three-parent mitochondrial gene therapy. Science. https://doi.org/10.1126/science.aaa7793.

    Google Scholar 

  • Zwart, Hub. 2012. On decoding and rewriting genomes: A psychoanalytical reading of a scientific revolution. Medicine, Health Care and Philosophy 15 (3): 337–346. https://doi.org/10.1007/s11019-011-9351-y.

    Article  Google Scholar 

Download references

Acknowledgements

I thank the journal’s anonymous reviewers for their comments, crucial suggestions and encouragement.

Funding

This paper is supported by funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 750088 (Artificial Life/Anthropological and Sociological Analysis of Life Engineering).

Author information

Authors and Affiliations

  1. Institute of Sociology, Research Group: “Biotechnologies, Nature and Society”, Goethe University Frankfurt, Frankfurt am Main, Germany

    Eva Šlesingerová

Authors
  1. Eva Šlesingerová
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eva Šlesingerová.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Šlesingerová, E. In risk we trust/Editing embryos and mirroring future risks and uncertainties. Med Health Care and Philos 22, 191–200 (2019). https://doi.org/10.1007/s11019-018-9851-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11019-018-9851-0

Keywords

  • Editing life
  • Editing embryos
  • Life-engineering
  • Biopower
  • Risk
  • Uncertainty